$18.64
-0.71-3.69%
Last update: Nov 10, 10:19 AM
Immunome Inc (IMNM) Stock Price, Quote, News & History
IMNMNASDAQ
Immunome posted a wider Q3 loss than expected, shares fell 4.6%, and analysts cut price targets despite oncology pipeline progress.
You can purchase shares of Immunome (NASDAQ:IMNM) through any online brokerage.
Other companies in Immunome’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Immunome has a consensus price target of $32.00.
The stock price for Immunome (NASDAQ: IMNM) is $18.645 last updated November 10, 2026 at 10:19 AM EST.
There are no upcoming dividends for Immunome.
Immunome does not have any upcoming earnings scheduled.
There is no upcoming split for Immunome.
Immunome is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other...
